Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign

被引:48
作者
Tobari, Maki [1 ]
Hashimoto, Estuko [3 ]
Taniai, Makiko [3 ]
Ikarashi, Yuuichi [3 ]
Kodama, Kazuhisa [3 ]
Kogiso, Tomomi [3 ]
Tokushige, Katsutoshi [3 ]
Takayoshi, Nishino [1 ]
Hashimoto, Naotake [2 ]
机构
[1] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Internal Med & Gastroenterol, Chiba, Japan
[2] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Internal Med, Chiba, Japan
[3] Tokyo Womens Med Univ, Inst Gastroenterol, Internal Med, Tokyo, Japan
关键词
gender difference; histology; NAFLD; NASH; nonobese patients; FATTY LIVER-DISEASE; BODY-MASS INDEX; HISTOLOGICAL SEVERITY; NONOBESE PATIENTS; SCORING SYSTEM; FIBROSIS; SARCOPENIA; PNPLA3; RISK; PROGRESSION;
D O I
10.1111/jgh.14585
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim To elucidate features of nonobese non-alcoholic fatty liver disease (NAFLD), we assessed Japanese patients with NAFLD stratified by body mass index (BMI) and by sex. Methods Biopsy-proven 762 NAFLD patients (404 men) were classified into three groups by the Japanese criteria: nonobese group (BMI < 25 kg/m(2)), obese group (25 to 30), and severely obese group (>= 30). Clinicopathological features and single nucleotide polymorphism of patatin-like phospholipase 3 (PNPLA3) rs738409 were investigated, and body composition analysis was performed by bioelectrical impedance analysis and computed tomography. Results Over 25% of men and almost 40% of women were nonobese, but most of them had visceral fat obesity and/or insulin resistance. The median age (years) of the nonobese, obese, and severely obese men was 49.9, 46.8, and 40.5 (P < 0.01), respectively, while those of women was 60.2, 59.6, and 48.5 (P < 0.01), respectively. The prevalence of metabolic comorbidities and PNPLA3 risk alleles did not differ among these groups in both sexes. Also, the prevalence of non-alcoholic steatohepatitis was not significantly different in both sexes, although nonobese patients had a higher prevalence of mild steatosis. Advanced fibrosis showed a marked difference between men and women. Advanced fibrosis was significantly more frequent among severely obese men (nonobese: 31.0%, obese: 41.6%, severely obese: 60.9%; P < 0.01), but it was lower among severely obese women (51.4%, 62.9%, 33.7%; P < 0.01). Skeletal muscle mass was significantly lower in nonobese patients. Conclusions Non-alcoholic fatty liver disease was not milder in nonobese patients. Histological steatosis was associated with BMI, but advanced fibrosis was not and showed a significant sex difference.
引用
收藏
页码:1404 / 1410
页数:7
相关论文
共 35 条
  • [1] Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians
    Abate, Nicola
    Chandalia, Manisha
    [J]. GASTROENTEROLOGY, 2017, 152 (07) : 1647 - 1655
  • [2] Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels
    Akyuz, Umit
    Yesil, Atakan
    Yilmaz, Yusuf
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) : 341 - 346
  • [3] Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh
    Alam S.
    Gupta U.D.
    Alam M.
    Kabir J.
    Chowdhury Z.R.
    Alam A.K.M.K.
    [J]. Indian Journal of Gastroenterology, 2014, 33 (5) : 452 - 457
  • [4] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [5] [Anonymous], 2016, Diabetologia, DOI [10.1016/j.jhep.2015.11.004, DOI 10.1007/S00125-016-3902-Y]
  • [6] Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
    Barba, C
    Cavalli-Sforza, T
    Cutter, J
    Darnton-Hill, I
    Deurenberg, P
    Deurenberg-Yap, M
    Gill, T
    James, P
    Ko, G
    Miu, AH
    Kosulwat, V
    Kumanyika, S
    Kurpad, A
    Mascie-Taylor, N
    Moon, HK
    Nishida, C
    Noor, MI
    Reddy, KS
    Rush, E
    Schultz, JT
    Seidell, J
    Stevens, J
    Swinburn, B
    Tan, K
    Weisell, R
    Wu, ZS
    Yajnik, CS
    Yoshiike, N
    Zimmet, P
    [J]. LANCET, 2004, 363 (9403) : 157 - 163
  • [7] Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
    Bedossa, Pierre
    [J]. HEPATOLOGY, 2014, 60 (02) : 565 - 575
  • [8] Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
    Bedossa, Pierre
    Poitou, Christine
    Veyrie, Nicolas
    Bouillot, Jean-Luc
    Basdevant, Arnaud
    Paradis, Valerie
    Tordjman, Joan
    Clement, Karine
    [J]. HEPATOLOGY, 2012, 56 (05) : 1751 - 1759
  • [9] Sarcopenia in Hiding: The Risk and Consequence of Underestimating Muscle Dysfunction in Nonalcoholic Steatohepatitis
    Bhanji, Rahima A.
    Narayanan, Praveena
    Allen, Alina M.
    Malhi, Harmeet
    Watt, Kymberly D.
    [J]. HEPATOLOGY, 2017, 66 (06) : 2055 - 2065
  • [10] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357